Tumor progression and resistance to chemotherapy and radiotherapy may also be activated through the suppression of Bax and upregulation of IGF-1R, resulting in increased proliferation and reduced apoptosis caused by upregulation of Bcl-2 and overexpression of altered p53 [63]. The gene discussed is BAX; the disease is neoplasm.